Involvement of tumor necrosis factor-α receptor 1 and tumor necrosis factor-related apoptosis-inducing ligand-(TRAIL) receptor-2/DR-5, but not Fas, in graft injury in live-donor liver transplantation

被引:13
|
作者
Tashiro, H
Itamoto, T
Ohdan, H
Arihiro, K
Tateaki, Y
Nakahara, H
Ochi, M
Hino, H
Mizunuma, K
Hara, H
Tokita, D
Onoe, T
Ishiyama, K
Mitsuta, H
Sugino, K
Asahara, T
机构
[1] Hiroshima Univ, Fac Med, Dept Surg 2, Minami Ku, Hiroshima 7348551, Japan
[2] Hiroshima Univ Hosp, Dept Pathol, Hiroshima, Japan
[3] Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, Dev Biol Lab, Hiroshima, Japan
关键词
ischemia; reperfusion injury; apoptosis; necrosis; liver allograft; death receptor;
D O I
10.1007/s00147-004-0762-z
中图分类号
R61 [外科手术学];
学科分类号
摘要
The pathway leading to cell death in clinical liver transplantation is not known. Eight liver transplant recipients and eight donors were enrolled in this study. Postoperative serum levels of alanine transferase had significantly increased in the recipients compared with those in the donors. Mild centri-lobular necrosis was observed in only liver tissues taken from the recipients. Tumor necrosis factor (TNF)-R1 and death receptor 5 expression levels had increased in liver tissues taken from the recipients. There were no changes in the levels of Fas/Fas ligand expression in liver tissues from either the donors or recipients. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression was down-regulated in donor liver after hepatectomy and liver allograft after implantation. The results suggest that, although ischemic liver injury was not serious, due to the short ischemia time, TNF and TRAIL signals are associated with liver ischemic injury in live-donor liver transplantation but Fas signal is not.
引用
收藏
页码:626 / 633
页数:8
相关论文
共 50 条
  • [1] Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-1 and receptor-2 agonists for cancer therapy
    Fox, Norma Lynn
    Humphreys, Robin
    Luster, Troy A.
    Klein, Jerry
    Gallant, Gilles
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (01) : 1 - 18
  • [2] The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis
    Michowitz, Y
    Goldstein, E
    Roth, A
    Afek, A
    Abashidze, A
    Ben Gal, Y
    Keren, G
    George, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (07) : 1018 - 1024
  • [3] Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) during liver regeneration
    Yamaguchi, Y
    Shiraki, K
    Saitou, Y
    Nakano, T
    Mizuno, S
    Uemoto, S
    JOURNAL OF HEPATOLOGY, 2004, 40 (04) : 718 - 719
  • [4] Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Receptor Expression in Patients with Neuroendocrine Neoplasia
    Saettele, R.
    Jann, H.
    Fischer, C.
    Pape, U. F.
    Schefold, J. C.
    Koschny, R.
    Pschowski, R.
    NEUROENDOCRINOLOGY, 2018, 106 : 17 - 17
  • [5] Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) pathway signaling
    Thorburn, Andrew
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (06) : 461 - 465
  • [6] Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Induces Death Receptor 5 Networks That Are Highly Organized
    Valley, Christopher C.
    Lewis, Andrew K.
    Mudaliar, Deepti J.
    Perlmutter, Jason D.
    Braun, Anthony R.
    Karim, Christine B.
    Thomas, David D.
    Brody, Jonathan R.
    Sachs, Jonathan N.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (25) : 21265 - 21278
  • [7] Involvement of tumor necrosis factor-retated apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases
    Saitou, Y
    Shiraki, K
    Fuke, H
    Inoue, T
    Miyashita, K
    Yamanaka, Y
    Yamaguchi, Y
    Yamamoto, N
    Ito, K
    Sugimoto, K
    Nakano, T
    HUMAN PATHOLOGY, 2005, 36 (10) : 1066 - 1073
  • [8] Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis
    Kohlhaas, Susan L.
    Craxton, Andrew
    Sun, Xiao-Ming
    Pinkoski, Michael J.
    Cohen, Gerald M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (17) : 12831 - 12841
  • [9] Roles of tumor necrosis factor-related apoptosis-inducing ligand in corneal transplantation
    Xie, LX
    Shi, WY
    Guo, P
    TRANSPLANTATION, 2003, 76 (11) : 1556 - 1559
  • [10] Expression of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Receptor DR5 in Ewing Sarcoma Family Tumors (ESFT)
    Galli, S.
    Li, G.
    Ren, Y.
    Tsokos, M.
    MODERN PATHOLOGY, 2009, 22 : 346A - 346A